期刊文献+

凉血止血法与活血通络法调节RVO兔模型凝血因子及微循环作用机制的研究 被引量:5

Research on blood coagulation factors and microcirculation in RVO rabbits with treatment of Liangxue Zhixue method and Huoxue Tongluo method
下载PDF
导出
摘要 目的探讨凉血止血法及活血化瘀法调节兔RVO凝血因子及微循环的作用机理。方法按照随机对照实验设计,采用新西兰兔39只(共78眼),其中正常对照组3只(6眼),余36只应用光化学方法建立RVO兔模型,随机分为4组:模型组、止血组、活血组、止血+活血组,每组9只(18眼),分别予生理盐水、十灰散、血府逐瘀汤、十灰散合血府逐瘀汤干预,观察血清凝血因子ATⅢ、PLG及微血管舒缩因子TXB2/6-Keto-PGF1α变化情况。结果 1.止血组在3 d以内降低ATⅢ活性,有促凝血作用;3~14 d使ATⅢ、PLG升高,有抗凝作用;28 d PLG仍升高而ATⅢ趋向正常。3~14 d下调TXB2/6-Keto-PGF1α比值,呈舒血管状态;28 d比值上调,血管趋于收缩。2.活血组1~14 d升高ATⅢ、PLG活性,以7 d内最显著,具有抗凝作用;28 d时下调ATⅢ、PLG,有促凝作用。3 d下调TXB2/6-Keto-PGF1α比值,呈舒血管状态;7~28 d上调比值,血管趋于收缩。3.止血+活血组以升高ATⅢ、PLG为主,具有抗凝作用,在7 d时上调ATⅢ最明显,在28 d时上调PLG较明显。3 d下调TXB2/6-Keto-PGF1α比值,呈舒血管状态;7~28 d上调比值,呈缩血管状态。结论凉血止血法以极早期(3天内)促凝及早中期的抗凝和舒张血管作用为主;活血通络法以早中期的抗凝和舒血管及中后期的促凝和收缩血管作用为主;两法合用者各期均以抗凝作用为主,其早期有较强的舒张血管作用,中晚期有收缩血管作用。三组中药对凝血及微循环调节的作用强度及时间点各有不同。 OBJECTIVE To study the mechanism of blood coagulation factors and microcirculation in RVO rabbits treated with Liangxue Zhixue method,Huoxue Tongluo method.METHODS Researched on 39 rabbits(78 eyes) with randomized controlled trials.There were 3 rabbits(6 eyes) in normal control group.Others were established to be RVO model with photochemical method.Divided models into 4 groups,9 rabbits(18 eyes) each,then treated model-controlled group with physiological saline,Zhixue group with Shihui Powder,Huoxue group with Xuefu Zhuyu Decoction,Zhixue-Huoxue group with both prescriptions.Tested level of antithrombin Ⅲ and plasminogen in blood,TXB 2 /6-Keto-PGF 1α in retinal tissue.RESULTS 1.In Zhixue group,the level of ATIII had reduced in first 3 days,it tended to procoagulanting.In 3~14d,the activity of both ATIII and PLG had risen,led to effect of anticoagulanting.At 28th day,ATIII presented to normal level.In 3~14 d,the activity of TXB 2 /6-Keto-PGF 1α had down-regulated,presented effect of expanding vascular.At 28th day,the activity of TXB 2 /6-Keto-PGF 1α had risen,presented effect of concentrating vascular.2.In Huoxue group,the activity of ATIII and PLG had increased in 1~14d,especially in first 7 days,led to effect of anticoagulanting.At 28th day,the level of ATIII and PLG had reduced,tended to pro-coagulanting.The level of TXB 2 /6-Keto-PGF 1α had decreased at 3rd day,presented effect of expanding vascular;then increased in 7 ~28 d,presented effect of concentrating vascular.3.In Huoxue Zhixue group,the activity of ATIII and PLG had increased in each period,AT Ⅲ was the highest at 7th day,PLG the highest at28th day,led to effect of anticoagulanting.The level of TXB 2 /6-Keto-PGF 1α had decreased at 3rd day,presented effect of expanding vascular;then increased in 7~28 d,presented effect of concentrating vascular.CONCLUSIONS Liangxue Zhixue method had effect of procoagulanting in first 3 days,then had anticoagulanting and expanding vascular in early period and mid-term.Huoxue Tongluo method had effect of anticoagulanting and expanding vascular in early period and mid-term,but concentrating vascular in mid-term and later period.With two methods combined,it had obvious effect of anticoagulanting in each period,the stronger effect of expanding vascular than other groups in early period,and the similar effcct with Huoxue Tongluo method of concentrating vascular in mid-term and later period.In summary,there were differences in time points and intensity among three treatment groups.
出处 《中国中医眼科杂志》 2013年第1期2-6,共5页 China Journal of Chinese Ophthalmology
基金 国家自然科学基金资助项目(81041037)
关键词 凉血止血法 活血通络法 凝血 微循环调节 视网膜静脉阻塞 Liangxue Zhixue method Huoxue Tongluo method blood coagulation adjustment microcirculation retinal vein occlusion(RVO)
  • 相关文献

参考文献7

  • 1李凤鸣.中华眼科学[M].北京:人民卫生出版社,2005.2467-2473.
  • 2Bezemer ID, Bare LA, Doggen C J, et al.Gene variants associated with deep vein thrombosis[J]. JAMA, 2008,299 ( 11 ) : 1306-1314.
  • 3Yamanobe S, Nakagawa Y, Hishinuma T, et al. Analysis of urinary 11-dehydrothromboxane B2 in patients with occluded retinal vein using GC/SIM [J].ProstaglandinsLeukot Essent FattyAcids, 1998,58 (1) :65-68.
  • 4Mizugaki M. Establishment of microanalysis of prostaglandin metabo- lites by GC/MS and its clinical application [J]. Yakugaku Zasshi, 1999,119(1 ) :61-80.
  • 5荣亮,任大元,房强.视网膜静脉阻塞患者血浆TXB_2、6-K-PGF_(1α)改变与气血辨证关系的研究[J].国际眼科杂志,2007,7(2):555-556. 被引量:7
  • 6清·唐宗海原著.血证论[M].上海:上海人民出版社,1977:18.
  • 7崔箭.十灰散止血、凝血作用机制研究[J].山东中医药大学学报,2004,28(6):463-466. 被引量:15

二级参考文献20

共引文献353

同被引文献42

  • 1詹宇坚,程慧君,余杨桂,王燕,张淳.补气活血法对兔视网膜静脉阻塞视网膜血管内皮细胞生长因子表达的影响[J].中国中医眼科杂志,2004,14(4):211-213. 被引量:14
  • 2李景恒,黄萍,詹宇坚,黄玲.三七和丹参对视网膜新生血管化小鼠血管内皮细胞生长因子的影响[J].中国临床康复,2005,9(30):96-97. 被引量:20
  • 3李凤鸣.中华眼科学[M].2版.北京:人民卫生出版社,2006:1222-1223.
  • 4葛坚.眼科学[M].2版.北京:人民卫生出版社,2010:496-500.
  • 5清·唐宗海..血证论[M]..上海:上海人民出版社,,1977:8,25..28-29..
  • 6Mitchell P, Smith W, Chang A. Prevalence and associations of reti- nal vein occlusion in Australia. The Blue Mountains Eye Study[J]. Arch Ophthalmo[, 1996,114 ( 10 ) : 1243-1247.
  • 7魏洁,孙时英.视网膜静脉阻塞的病因和影响视力预后的相关因素分析[D].乌鲁木齐:新疆医科大学,2012.
  • 8Binders S, Aggermann T, Brunner S. Eongterm effects of radial op- tic neurotomy for central retinal vein occlusion consecutive inter- ventional case series[J]. Graefes Arch Clin Exp Ophthalmol, 2007,245(10) : 1447-1452.
  • 9Hayreh SS, Zimmerman MB, Podhajsky P. Seasonal variations in the onset of retinal vein occlusion [J]. Br J Ophthalmol, 1992,76 (12) :706-710.
  • 10王永炎.中医内科学[M].上海:科学技术出版社,2000:131.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部